Dabigatran indications and usage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
Created page with "__NOTOC__ {{Argatroban}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvul..."
 
GeraldChi (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
8,887 edits
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Dabigatran#Adult Indications and Dosage]]
{{Argatroban}}
{{CMG}}; {{AE}} {{SS}}
 
==Indications and Usage==
 
PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher =  | date =  | accessdate = 31 January 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Direct thrombin (II) inhibitors]]
[[Category:Anticoagulants]]
[[Category:Cardiovascular Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 02:32, 22 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Dabigatran_indications_and_usage&oldid=998536"